Drug Shortage Report for PIPERACILLIN AND TAZOBACTAM FOR INJECTION
| Report ID | 101048 |
| Drug Identification Number | 02362619 |
| Brand name | PIPERACILLIN AND TAZOBACTAM FOR INJECTION |
| Common or Proper name | PIPERACILLIN AND TAZOBACTAM FOR INJECTION |
| Company Name | STERIMAX INC |
| Market Status | MARKETED |
| Active Ingredient(s) | PIPERACILLIN TAZOBACTAM |
| Strength(s) | 2.00G 0.25G |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | 10 VIALS |
| ATC code | J01CR |
| ATC description | BETA-LACTAM ANTIBACTERIALS, PENICILLINS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | |
| Actual start date | 2019-12-16 |
| Estimated end date | 2020-02-01 |
| Actual end date | 2020-01-21 |
| Shortage status | Resolved |
| Updated date | 2020-01-22 |
| Company comments | |
| Health Canada comments | |
| Contact Address | 2770 PORTLAND DRIVE OAKVILLE, ONTARIO CANADA L6H 6R4 |
| Company contact information | 1-800-881-3550 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.